PubRank

Lipidomics of human brain aging and Alzheimer's disease pathology.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 26358893)

Published in Int Rev Neurobiol on June 19, 2015

Authors

Alba Naudí1, Rosanna Cabré1, Mariona Jové1, Victoria Ayala1, Hugo Gonzalo1, Manuel Portero-Otín1, Isidre Ferrer2, Reinald Pamplona3

Author Affiliations

1: Department of Experimental Medicine, University of Lleida-Biomedical Research Institute of Lleida, Lleida, Spain.
2: Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, Biomedical Research Institute of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), ISCIII, Madrid, Spain.
3: Department of Experimental Medicine, University of Lleida-Biomedical Research Institute of Lleida, Lleida, Spain. Electronic address: reinald.pamplona@mex.udl.cat.

Articles citing this ↘

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD). BBA Clin (2015) 0.77

Effect of high fat diet on phenotype, brain transcriptome and lipidome in Alzheimer's model mice. Sci Rep (2017) 0.76

Specific Metabolomics Adaptations Define a Differential Regional Vulnerability in the Adult Human Cerebral Cortex. Front Mol Neurosci (2016) 0.75

The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome. PLoS One (2016) 0.75

Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging. PLoS One (2017) 0.75

Articles by these authors ⇆

Deregulation of purine metabolism in Alzheimer's disease. Neurobiol Aging (2014) 0.81